Compromising functional responses of certain immune-cell populations may delay the onset of obesity-associated chronic low-grade tissue inflammation and development of insulin resistance, but this could eventually be compensated by the activation of T cells via alternative IL-6 trans-signalling leading to prolonged activation of the inflammatory state and metabolic disorders in obesity. This evidence concerns the gene IL6 and Other metabolic disease.